|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_on1259509919 |
| 003 |
OCoLC |
| 005 |
20231120010552.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
210709s2021 enk o 000 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d OPELS
|d OCLCO
|d OCLCF
|d RDF
|d OCLCO
|d N$T
|d OCLCO
|d OCLCQ
|d OCLCO
|d K6U
|d SFB
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9780323903080
|q (electronic bk.)
|
| 020 |
|
|
|a 0323903088
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128202685
|
| 020 |
|
|
|z 0128202688
|
| 035 |
|
|
|a (OCoLC)1259509919
|
| 050 |
|
4 |
|a RA644.Z56
|
| 082 |
0 |
4 |
|a 616.9185
|2 23
|
| 245 |
0 |
0 |
|a Zika virus biology, transmission, and pathology.
|n Volume 1,
|p The neuroscience of Zika /
|c edited by Colin R. Martin, Caroline Hollins-Martin, Victor R. Preedy, Rajkumar Rajendram.
|
| 246 |
3 |
0 |
|a Neuroscience of Zika
|
| 260 |
|
|
|a London :
|b Academic Press,
|c 2021.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Intro -- Zika Virus Biology, Transmission, and Pathways: The Neuroscience of Zika Virus -- Copyright -- Dedication -- Contents -- Contributors -- Foreword -- Preface -- Section A: Zika virus: Introductory chapters -- Chapter 1: Flaviviruses and where the Zika virus fits in: An overview -- Classification, diversity, and evolution -- Biology of transmission and persistence of MBF and TBF -- Virion structure, genome, and viral protein function -- Viral infection and replication cycle -- Host infection, immune response, and pathogenesis -- Flavivirus emergence and global burden -- Emergence of Aedes-borne flaviviruses -- Emergence of Culex-borne flaviviruses -- Policy and procedures -- Vector-borne flaviviruses diagnoses -- Mini-dictionary of terms -- Key facts of flavivirus genera -- Summary points -- References -- Chapter 2: The innate immune response during Zika virus infection -- Introduction -- Importance of pattern recognition receptors (PRRs) in sensing ZIKV -- Type I interferon in ZIKV infection -- Innate immunity against ZIKV in the skin -- Innate immunity against ZIKV in the placenta -- Innate immunity against ZIKV in the brain -- Involvement of autophagy -- Innate immunity evasion by ZIKV -- Policy and procedures -- mRNA expression of innate immune receptors determined by real time PCR -- Measuring innate immune receptors protein expression by flow cytometry -- Analyzing innate immune receptors localization and function -- Mini-dictionary of terms -- Key facts of innate immune response in ZIKV infection -- Summary points -- References -- Chapter 3: The public health perspective of Zika virus infection -- Introduction -- Timeline of the outbreaks -- Epidemiology: Distribution and determinants -- Geographical distribution -- Epidemiological determinants -- Public health consequences -- Prevention and control of Zika virus infections.
|
| 505 |
8 |
|
|a Better and sustained preparedness -- Implementation of strategic response framework -- Strengthening of International Health Regulations: Advice to travelers -- Strengthening of the sexual and reproductive health services -- Vector control, surveillance, risk communication, and promotion of research -- Bridging the gap between social and health inequalities -- Conclusion -- Policy and procedures -- Mini-dictionary of terms -- Key facts of the Zika virus infections -- Summary points -- References -- Chapter 4: Inequality in Zika virus and congenital Zika syndrome -- Inequalities in health -- The macro-drivers of the ZIKV -- Socioeconomic inequality in the prevalence of CZS -- Inequality in the exposure to ZIKV -- Inequality in susceptibility to the effect of ZIKV on CZS -- Sources of differential susceptibility -- Inequality in vector density -- Inequality in the vulnerability to the effect of vector density on ZIKV incidence -- The fundamental determination of ZIKV inequalities -- Socioeconomic implications -- Major knowledge gaps -- Policies to tackle the inequalities -- Mini-dictionary of terms -- Key facts -- Summary points -- References -- Chapter 5: Lifestyle factors and congenital Zika syndrome: Drugs, alcohol, and beyond -- Introduction -- Socioeconomic condition -- Lifestyle -- Access to information/health education -- Health-care access -- Abortion legislation -- Human rights -- Policy and procedures -- Multidisciplinary follow-up -- Multicenter follow-up of cohorts -- Mini-dictionary of terms -- Key facts -- Key facts of birth control methods -- Key facts of causes of mal formation in newborns -- Summary points -- References -- Chapter 6: Economic impact of Zika virus infection and associated conditions -- Introduction -- Brief history of ZIKV -- Health economics -- Economic and social impacts of recent outbreaks.
|
| 505 |
8 |
|
|a The cost of vector control -- The cost of diagnosis -- The cost of ZIKV-associated microcephaly -- The cost of congenital Zika syndrome -- The costs of ZIKV-associated Guillain-Barr�e syndrome -- Understand the economic evaluation of health technologies -- Economic evaluation of current and emerging health technologies -- Policy and procedures -- Mini-dictionary of terms -- Key facts -- Summary points -- References -- Chapter 7: Health promotion, health education, and risk communication for Zika virus disease -- Health promotion and education program during a noncrisis situation -- Social assessment -- Epidemiological assessment -- Educational and ecological assessment -- Administrative and policy assessment and intervention alignment phase -- Implementation -- Process evaluation -- Impact evaluation -- Outcome evaluation -- Risk communication for Zika virus disease -- Mini-dictionary of terms -- Key facts of Zika virus disease or ZVD -- Summary points -- References -- Chapter 8: Molecular mechanisms of Zika virus-induced neurological pathology -- Introduction -- ZIKV impairs mitotic spindle assembly -- Premature neural progenitor cell differentiation during ZIKV infection decreases the number of mature neurons -- ZIKV induces apoptosis in infected and bystander cells -- ZIKV interferes with developmental gene expression programs -- Neuroinflammation -- Conclusions and outstanding questions -- Policy and procedures: Measuring apoptosis -- Mini-dictionary of terms -- Key facts of the unfolded protein response -- Summary points -- References -- Chapter 9: Validation of Zika virus infections: Nonmolecular aspects, immunoassays, and beyond -- Introduction -- Symptoms and diagnosis of ZIKV infection: Basics and guidance -- Serological methods used in diagnosing ZIKV infection -- Basics about ZIKV antibody detection -- Methods for detecting ZIKV antibodies.
|
| 505 |
8 |
|
|a Virus neutralization assays -- Hemagglutination inhibition and immunofluorescence assays -- Immunoassays for detecting anti-ZIKV IgM, IgG, and IgA antibodies -- Policy and procedures -- DENV vaccine -- Mini-dictionary of terms -- Key facts of immunoassays used for the diagnosis of ZIKV infection -- Summary points -- References -- Chapter 10: Validation of Zika virus infections: A focus on molecular methods -- Introduction -- Molecular methods: ZIKV nucleic acids -- Basics of the nucleic acid amplification tests (NAATs) -- Real-time RT-PCRs -- Multiplex real-time RT-PCRs -- Conventional RT-PCRs -- Validation criteria -- Policy and procedures -- Mini-dictionary of the terms -- Key facts of molecular tests used for diagnosis of ZIKV infection -- Summary points -- References -- Chapter 11: Coinfection of Zika with Dengue and Chikungunya virus -- Introduction -- Timeline of coinfections -- Distribution of coinfections -- Detection of arboviruses in coinfections -- Clinical outcomes of coinfections -- Coinfection with ZIKV and DENV -- Coinfection with ZIKV and CHIKV -- Triple coinfection with ZIKV, DENV, and CHIKV -- Conclusion -- Policy and procedures -- Mini-dictionary of terms -- Key facts -- Summary points -- References -- Chapter 12: Zika virus, pathology, and control: Zika vaccine strategies in development -- Introduction -- Adaptive immunity to ZIKV infection -- The humoral immune response to ZIKV -- The T-cell immune response to ZIKV -- Key challenges facing Zika vaccine development -- Target populations for ZIKV vaccination -- The protection afforded by ZIKV vaccination -- Zika vaccine platforms -- Whole virus-based vaccines -- Subunit virus-based vaccines -- Clinical evaluation of Zika vaccine candidates -- Concluding remarks -- Policy and procedures -- Mini-dictionary of terms -- Key facts on Zika vaccine -- Summary points -- References.
|
| 505 |
8 |
|
|a Section B: Effects on neurological and body systems -- Chapter 13: The adult brain and neurologic manifestations of the Zika virus -- Introduction -- Zika virus and the nervous system: NeuroZika -- Guillain-Barr�e syndrome -- ZIKV-GBS viral diagnosis -- ZIKV-GBS neuroimaging -- GBS-Zika virus treatment and prognosis -- Others neurological complications -- General implications -- Policy and procedures -- Using the Brighton collaboration GBS working group criteria for GBS diagnosis -- Mini-dictionary of terms -- Key facts of NeuroZika -- Summary points -- References -- Chapter 14: Postmortem studies: Contribution to understand the pathogenesis of congenital Zika syndrome -- Introduction -- Pathogenesis of the lesions in CZS -- Conclusions -- Policy and procedures -- Mini-dictionary of terms -- Key facts -- Key facts of congenital Zika syndrome (CZS) -- Summary points -- References -- Chapter 15: Developmental trajectories in infants and toddlers born with congenital Zika syndrome -- Introduction -- Zika virus and the developing brain -- Congenital Zika syndrome -- Motor development -- Cognitive development -- Communication skills -- General implications -- Policy and procedures -- Measuring head circumference -- Using standardized tests to evaluate developmental skills in infants with CZS -- Mini-dictionary of terms -- Key facts -- Summary points -- References -- Chapter 16: Host genetic susceptibility to ZIKV congenital syndrome: A tale of twins -- Introduction -- Zika virus in Brazil -- Congenital Zika syndrome: Reasons for studying ZIKV effects in humans -- Risks for ZIKV-associated microcephaly and other CZS symptoms -- Twins: A powerful tool for investigating risks for ZIKV-associated microcephaly and CZS -- Twins cells are differentially infected by ZIKV -- Investigating the molecular NPCs twins differences -- Conclusion and follow-up.
|
| 650 |
|
0 |
|a Zika virus.
|
| 650 |
|
0 |
|a Zika virus infection.
|
| 650 |
|
2 |
|a Zika Virus
|0 (DNLM)D000071244
|
| 650 |
|
2 |
|a Zika Virus Infection
|0 (DNLM)D000071243
|
| 650 |
|
6 |
|a Virus Zika.
|0 (CaQQLa)000296024
|
| 650 |
|
6 |
|a Infections �a virus Zika.
|0 (CaQQLa)000296026
|
| 650 |
|
7 |
|a Zika virus
|2 fast
|0 (OCoLC)fst01938813
|
| 650 |
|
7 |
|a Zika virus infection
|2 fast
|0 (OCoLC)fst01938788
|
| 700 |
1 |
|
|a Martin, Colin R.,
|d 1964-
|
| 700 |
1 |
|
|a Hollins Martin, Caroline.
|
| 700 |
1 |
|
|a Preedy, Victor R.
|
| 700 |
1 |
|
|a Rajendram, Rajkumar.
|
| 776 |
0 |
8 |
|i Print version:
|z 0128202688
|z 9780128202685
|w (OCoLC)1240491501
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128202685
|z Texto completo
|
